Diebold Nixdorf (DBD) Tops Q4 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $57.98 +3.87%
Financial Fact:
Net income attributable to Diebold, Incorporated: -21.1M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Net income attributable to Diebold, Incorporated: -21.1M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q4 EPS of $0.44, $0.08 better than the analyst estimate of $0.36. Revenue for the quarter came in at $1.11 billion versus the consensus estimate of $1.07 billion.
GUIDANCE:
Diebold Nixdorf sees 2021 revenue of $4-4.1 billion, versus the consensus of $4.09 billion.
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- Socket Mobile (SCKT) Reports Q3 Loss of $0.09
- Relay Therapeutics, Inc. (RLAY) Tops Q3 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
